Research

Home/Research

Real World Evidence in Action: The LRG Research Model

Although targeted medicine has brought about immense progress in cancer treatment, there are still enormous challenges regarding patient survival. Randomized clinical trials (RCTs) driven by lab-based research have been the gold standard for identifying new [...]

By |2019-02-20T08:46:19-05:00August 15th, 2018|News, Research|

LRG Discusses Importance of Real World Evidence in GIST Research at the FDA

On April 6th, 2018, Executive Director, Norman Scherzer; Data Analyst, Jerry Call; Real World Evidence Scientist, Yu Wang, and Patient Registry Director, Denisse Montoya, of The Life Raft Group, were invited to present at [...]

By |2018-10-29T13:42:27-04:00June 29th, 2018|Newsletter, Research|

GIST Updates from the ASCO Annual Meeting 2018

Executive Director, Norman Scherzer, and Real World Evidence Data Scientist, Dr. Yu Wang, of the Life Raft Group recently attended the ASCO (American Society of Clinical Oncologists) 2018 meeting in Chicago. Dr. Wang describes [...]

By |2018-10-29T13:43:20-04:00June 18th, 2018|Clinical Trials, News, Research|

Latest Issue of the GIST and Sarcoma Journal is Now Available Online

The latest edition of the GIST and Sarcoma Journal is now available online. The GIST and Sarcoma Journal is a comprehensive and authoritative resource for scientifically valid information for physicians, allied healthcare professionals [...]

By |2018-10-30T09:19:21-04:00May 18th, 2017|News, Research|

New Data Indicates Imatinib Boosts Long-Term Survival for Some GIST Patients

A significant finding from a newly published study in JAMA Oncology, indicates that nearly one-fourth of GIST patients with advanced disease initially treated with imatinib will survive for ten years or more. The study, [...]

By |2018-10-30T09:19:32-04:00February 27th, 2017|News, Research|